Collaboration Oriented Approach to Controlling High Blood Pressure
Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · Nov 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the COACH study, is focused on finding better ways to help people manage high blood pressure, which is a major cause of heart-related health problems. The researchers have developed an app called COACH that helps patients keep track of their blood pressure readings at home and share this information with their doctors. The goal is to see if using this app can improve how well patients manage their blood pressure, especially in primary care settings.
To participate in this trial, you need to be an adult aged 18 to 100, have high blood pressure, and be receiving care at a clinic involved in the study. It's also important that your doctor thinks you would benefit from monitoring your blood pressure at home. If you join the study, you’ll use the COACH app to help track your blood pressure and communicate with your healthcare team. The trial is currently recruiting participants, so if you meet the criteria and are interested, it could be a great opportunity to take an active role in managing your health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients aged 18-100 years old
- • Patient receives care at a participating primary care clinic and has been seen in the last year
- • Patient has high BP, defined as an average of 4 BPs \> 140 systolic or \> 90 diastolic (clinic) or \> 135 OR \> 85 (home)
- • Patient is enrolled in online health portal
- • Patient can communicate in English
- • Patient has been recommended by their physician who thinks the patient would benefit from a home blood pressure monitoring program.
- Exclusion Criteria:
- • Patient is pregnant at the time of consent
- • Patient who, in the opinion of the primary care clinician, has severe cognitive impairment
- • Patient is on hospice care and/or has a life expectancy of less than 2 years
- • Patient has end stage renal disease
- • Patient for whom tight blood pressure control presents a greater risk, such as those with a history of adverse events from hypertension treatment (falls, dizziness, electrolyte disturbances, hypotension, active heart failure)
- • Patient has any other disease or disorder that in the opinion of the investigator or the patient's primary care clinician, could put participants at risk and affect trial results, or hinder participation will exclude them from participating
About Oregon Health And Science University
Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Nashville, Tennessee, United States
Portland, Oregon, United States
Columbia, Missouri, United States
Patients applied
Trial Officials
David Dorr, MD, MS, FACMI, FAMIA
Principal Investigator
Oregon Health and Science University
Richelle Koopman, MD
Principal Investigator
University of Missouri-Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported